Investigating Myocardial Remodelling in the Failing Human Heart
NCT ID: NCT05303896
Last Updated: 2025-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2022-05-30
2030-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Complex Pathophysiological Background of Heart Failure Deterioration
NCT02355769
Predictors of an Unfavorable Outcome in Patients With Heart Failure
NCT04753814
Heart Failure in Norway: Clinical Characteristics, Mortality and Health Care Resource Use
NCT04398563
Pathophysiological Mechanisms of Activity-Related Dyspnea in Heart Failure: A Pilot Study
NCT02007486
A Study to Observe Treatment Patterns in Patients in Colombia Who Have Heart Failure
NCT05036967
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness to participate in the present study and ability to understand and sign the written informed consent
Exclusion Criteria
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ivar Sjaastad
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ivar Sjaastad, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Oslo, Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital
Oslo, Oslo County, Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
230524
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.